GBIO
Price
$2.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
INZY
Price
$4.78
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

GBIO vs INZY

Header iconGBIO vs INZY Comparison
Open Charts GBIO vs INZYBanner chart's image
Generation Bio
Price$2.34
Change-$0.00 (-0.00%)
Volume$70.15K
CapitalizationN/A
Inozyme Pharma
Price$4.78
Change-$0.00 (-0.00%)
Volume$245.27K
CapitalizationN/A
View a ticker or compare two or three
GBIO vs INZY Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GBIO vs. INZY commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and INZY is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (GBIO: $2.39 vs. INZY: $4.62)
Brand notoriety: GBIO and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 92% vs. INZY: 113%
Market capitalization -- GBIO: $162.18M vs. INZY: $347.57M
GBIO [@Biotechnology] is valued at $162.18M. INZY’s [@Biotechnology] market capitalization is $347.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while INZY’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 5 bearish.
  • INZY’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than INZY.

Price Growth

GBIO (@Biotechnology) experienced а +2.58% price change this week, while INZY (@Biotechnology) price change was -9.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

GBIO is expected to report earnings on Feb 20, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($348M) has a higher market cap than GBIO($162M). GBIO YTD gains are higher at: 41.818 vs. INZY (12.207). INZY has higher annual earnings (EBITDA): -82.82M vs. GBIO (-107.1M). GBIO has more cash in the bank: 217M vs. INZY (145M). INZY has less debt than GBIO: INZY (46.7M) vs GBIO (94M). GBIO has higher revenues than INZY: GBIO (13.2M) vs INZY (0).
GBIOINZYGBIO / INZY
Capitalization162M348M47%
EBITDA-107.1M-82.82M129%
Gain YTD41.81812.207343%
P/E RatioN/AN/A-
Revenue13.2M0-
Total Cash217M145M150%
Total Debt94M46.7M201%
TECHNICAL ANALYSIS
Technical Analysis
GBIOINZY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+9.35%
EDIT - GBIO
48%
Loosely correlated
+2.52%
TECH - GBIO
47%
Loosely correlated
+2.48%
INZY - GBIO
47%
Loosely correlated
-0.21%
NTLA - GBIO
47%
Loosely correlated
+2.45%
BEAM - GBIO
46%
Loosely correlated
+3.71%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-0.21%
BEAM - INZY
59%
Loosely correlated
+3.71%
NTLA - INZY
52%
Loosely correlated
+2.45%
DNLI - INZY
51%
Loosely correlated
+6.27%
PLRX - INZY
50%
Loosely correlated
+5.02%
ALLO - INZY
50%
Loosely correlated
+9.84%
More